In 2008, the group companies active in the field of medical biomaterials („aap bio implants group“), achieved sales of EUR19.4 million (previous year: EUR18.8 million, + 3%). This development is based on the considerably cautious customers’ order behavior (reduction of inventories) as well as delays in planned approvals of new products.
The Berlin based trauma & orthopaedics division of the company reached for the full financial year 2008 a strong organic sales increase of 28% to EUR11.8 million (previous year: EUR9.2 million).
The full year an annual financial statement 2008 is planned for April 17, 2009.
